Can audit results under the MDSP be shared across different countries?

• A. Yes, the results can be utilized by various participating regulatory bodies
• B. No, they are restricted to the country of the audit
• C. Only if doubles in revenue are reported
• D. Yes, but only with prior consent from the audited party

Answer: (A)

The results of audits conducted under the Medical Device Single Audit Program (MDSP) can indeed be shared across different countries. This is because the MDSP aims to streamline the auditing process for medical device manufacturers by allowing regulatory bodies from participating countries to accept audit results performed by each other. This mutual recognition facilitates greater efficiency and consistency in the regulatory oversight of medical devices, reducing duplication of efforts and ultimately enhancing patient safety.

The benefit of sharing audit results lies in enabling regulatory agencies to collaborate and leverage information already gathered, which can save time and resources for both the manufacturers and the participating authorities. As a result, regulatory bodies can make informed decisions based on shared insights, improving overall compliance and monitoring in the global market.

Other options, like restricting the results to the country of audit or requiring specific revenue conditions for sharing, do not align with the MDSP's goals and purpose, which foster cooperation and mutual recognition among countries for efficient regulation.